Mineralys Therapeutics, Inc. Contracts & Agreements
23 Contracts & Agreements
- Business Finance (7 contracts)
- Business Operations (1)
- Human Resources (8)
- Intellectual Property (1)
- Uncategorized (6)
- Description of Registered Securities (Filed With SEC on March 21, 2024)
- Securities Purchase Agreement, dated February 7, 2024, by and between Mineralys Therapeutics, Inc. and each of the purchasers party thereto (Filed With SEC on February 8, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 8, 2024)
- Description of Registered Securities (Filed With SEC on March 15, 2023)
- Amended and Restated (Filed With SEC on February 2, 2023)
- Amended and Restated Employment (Filed With SEC on February 2, 2023)
- Amended and Restated Employment (Filed With SEC on February 2, 2023)
- Amended and Restated Employment (Filed With SEC on February 2, 2023)
- Non-Employee Director Compensation Policy (Filed With SEC on February 2, 2023)
- Mineralys Therapeutics, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on February 2, 2023)
- Mineralys Therapeutics, Inc. 2023 Incentive Award Plan and form of stock option agreement and form of restricted stock unit agreement thereunder (Filed With SEC on February 2, 2023)
- Mineralys Therapeutics, Inc. Amended and Restated 2020 Equity Incentive Plan and form of stock option agreement and form of restricted stock agreement thereunder (Filed With SEC on February 2, 2023)
- Specimen stock certificate evidencing the shares of common stock (Filed With SEC on February 2, 2023)
- Form of Underwriting Agreement (Filed With SEC on February 2, 2023)
- Amended and Restated Investors Rights Agreement, dated June 1, 2022, by and among the Registrant and certain of its stockholders (Filed With SEC on January 18, 2023)
- License Agreement, dated July 9, 2020, between the Registrant and Mitsubishi Tanabe Pharmaceutical Corporation (Filed With SEC on January 18, 2023)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on January 18, 2023)
- Offer Letter Agreement, dated March 8, 2022, by and between Adam Levy and the Registrant (Filed With SEC on January 18, 2023)
- Offer Letter Agreement, dated January 8, 2021, by and between David Rodman, M.D. and the Registrant (Filed With SEC on January 18, 2023)
- Offer Letter Agreement, dated October 9, 2020, by and between Jon Congleton and the Registrant (Filed With SEC on January 18, 2023)
- Mineralys Therapeutics, Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on January 18, 2023)
- Mineralys Therapeutics, Inc. 2023 Incentive Award Plan and form of stock option agreement and form of restricted stock unit agreement thereunder (Filed With SEC on January 18, 2023)
- Mineralys Therapeutics, Inc. Amended and Restated 2020 Equity Incentive Plan and form of stock option agreement and form of restricted stock agreement thereunder (Filed With SEC on January 18, 2023)
